ClinicalTrials.gg
Sign In

Child Development Disorders, Pervasive clinical trials

The registry lists 117 studies for Child Development Disorders, Pervasive across more than 10 countries. 15 are recruiting or about to start. 17 of them are mainly about Child Development Disorders, Pervasive (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-21. Counting its 3 narrower conditions too, such as Autism Spectrum Disorder: 2,287 studies, 621 open.

Get an email when these change. Save the Child Development Disorders, Pervasive studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
72
Status unknown
12
Terminated
9
Recruiting
8
Withdrawn
6
Not yet recruiting
4

Phase

Phase 2
22
Phase 3
9
Phase 1
8
Phase 4
5

Where

United States
76
Israel
4
Hong Kong
4
Taiwan
4
Brazil
3
Canada
3

Who runs them

Massachusetts General Hospital (11) · National Institute of Mental Health (NIMH) (6) · Yale University (6) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (3) · Children's Hospital Medical Center, Cincinnati (3) · National Taiwan University Hospital (3) · University of Pittsburgh (2) · University of Arkansas (2)

What is being tested here

Drugs under test in Child Development Disorders, Pervasive studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Aripiprazole015
Risperidone025
Buspirone003
Memantine002
Oxytocin012
Olanzapine002
Sulforaphane001
Guanfacine001
Mirtazapine011
Glycerol001

Drug classes tested here Antipsychotics 12

Coming up

0phase 3 studies under way
4studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 4

Who these studies take

Of the 8 Child Development Disorders, Pervasive studies recruiting now, 2 (25%) set no upper age limit and 6 (75%) stop at 75 or younger. 6 (75%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (13%) take healthy volunteers.

Recruiting studies that take each age, of 8
AgeWomenMen
104 (50%)4 (50%)
185 (63%)5 (63%)
303 (38%)3 (38%)
403 (38%)3 (38%)
502 (25%)2 (25%)
652 (25%)2 (25%)
752 (25%)2 (25%)
852 (25%)2 (25%)

Across all 117 studies, recruiting or not: 88% stop at 75 or younger and 88% at 65; 86% take children; 2% are for women only and 3% for men only; 20% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Child Development Disorders, Pervasive studies take

Of 30 interventional studies with no phase under Child Development Disorders, Pervasive, half reached primary completion within 26 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase26 mo9–68 · 30 studies—26 mo9–64 · 29 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 117. Browse all 117 → or search them.